Blockade of the high-affinity norepinephrine transporter -NET- by the selective serotonin reuptake inhibitor escitalopram- an in vivo microdialysis study in mice-
Send a publication request
close

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.




- Categories : Depression , Mood disorders , Publications - ID: 373

Authors
H. Nguyen, B. Guiard, A. Bacq, D. David, I. David et al.


Lab
Université Paris-Sud XI, Faculté de Pharmacie, Lab. Neuropharmacologie, Châtenay-Malabry, France. ; Neuropharmacological. Res., Copenhagen, Denmark ; INSERM U952, Paris, France ; CNRS UMR 7224, Paris, France ; UPMC Univ Paris 06, Paris, France.

Journal
British Journal of Pharmacology

Abstract
Background and Purpose_ Escitalopram, the S(+)-enantiomer of citalopram is the most selective serotonin (5-HT) reuptake inhibitor approved. Although all serotonin selective reuptake inhibitors (SSRIs) increase extracellular levels of serotonin ([5-HT](ext) ), some of them also enhance, to a lower extent, extracellular levels of norepinephrine ([NE](ext) ). However, the mechanisms by which SSRIs activate noradrenergic transmission in the brain remain to be determined. Experimental approach_ This study aimed at examining the effects of escitalopram, on both [5-HT](ext) and [NE](ext ) in the frontal cortex (FCx) of freely moving wild-type (WT) and mutant mice lacking the 5-HT transporter (SERT(-/-) ) by using intracerebral microdialysis. In particular, the possibilities that escitalopram enhances [NE](ext) either by a direct mechanism involving the inhibition of the low- or high-affinity NE transporters, or by an indirect mechanism promoted by [5-HT](ext) elevation were explored. The forced swim test (FST) was used to investigate whether enhancing cortical [5-HT](ext) and/or [NE](ext) affected the antidepressant-like activity of escitalopram. Key results_ In WT mice, a single systemic administration of escitalopram produced a significant increase in cortical [5-HT](ext ) and [NE](ext) . As expected, escitalopram failed to increase cortical [5-HT](ext) in SERT(-/-) mice whereas its neurochemical effects on [NE](ext) persisted in these mutants. In WT mice submitted to the FST, escitalopram increased swimming parameter without affecting climbing behavior. Finally, escitalopram, at relevant concentrations, failed to inhibit cortical NE and 5-HT uptake mediated by low-affinity monoamine transporters. . Conclusions and implications_ These experiments suggest that escitalopram enhances, although moderately, cortical [NE](ext) in vivo by a direct mechanism involving the inhibition of the high-affinity NE transporter (NET).

BIOSEB Instruments Used:
Forced Swimming Test: New FST DUAL SENSOR (BIO-FST-DSM)

Share this content